Are Assessment Guidelines for HER2 Status Leading to Many False Positives?

Researchers tested whether the use of recommended alternative control probes to classify HER2 status in breast cancer could lead to substantial false positives.

Source: CancerNetwork - April 2, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news